menu search

Fate therapeutics to present at upcoming september investor conferences

SAN DIEGO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage b...

August 31, 2023, 8:00 am

Hillevax: takeda's norovirus vaccine spinout

HilleVax is developing a virus-like particle vaccine candidate, HIL-214, for norovirus-induced acute gastroenteritis. Norovirus is highly contagious a...

August 30, 2023, 7:32 pm

Iovance: november pdufa, but a history of delays and underwhelming data

Iovance Biotherapeutics, Inc. has a deep pipeline of cancer immunotherapies, but has faced delays and i...

August 30, 2023, 4:01 pm

Merck's (mrk) keytruda receives eu nod in gastric cancer

Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-...

August 30, 2023, 1:31 pm

Serina therapeutics merger promises to reboot ‘human longevity' firm agex

Privately-owned Serina Therapeutics Inc is being merged into AgeX Therapeutics (NYSE:AGE) in a move that will reboot the Nasdaq ‘human longevity' st...

August 30, 2023, 10:22 am

Willow biosciences files patent application for process to produce much cheaper corticosteroids

Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has filed a patent application for a process it has developed to produce corticostero...

August 30, 2023, 8:31 am

Argenx to present at upcoming investor conferences

August 30 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology...

August 30, 2023, 1:00 am

immunogen: takeda swoops for slice of elahere - adding to valuation uncertainty?

Yesterday, immunoGen, Inc. announced it has entered an exclusive licensing agreement with Takeda for th...

August 29, 2023, 1:45 pm

immunogen stock jumps after licensing deal with japan's takeda pharmaceutical

Shares of immunoGen Inc. IMGN, +1.45% jumped 1.7% in premarket trading Monday, after the Massachusetts-...

August 28, 2023, 6:50 am

Anchored in innovation: moonlake immunotherapeutics charts a new course (rating upgrade)

MoonLake immunotherapeutics' financial health improved with $501.8M cash reserves and robust Q2 2023 re...

August 27, 2023, 11:54 pm

immunocore: kimmtrak adoption continues at rapid pace, expanding to new markets, reiterate buy

immunocore's KIMMTRAK segment continues to see rapid adoption, expanding into additional European marke...

August 27, 2023, 12:28 pm

Lyell immunopharma: once huge ipo now waiting for clinical data

Lyell is a developer of personalized T-cell therapies for solid tumors, with two programs targeting various types of solid tumors. Their pipeline incl...

August 26, 2023, 9:29 am

Iteos therapeutics and the tigit ticket to cancer's downfall

iTeos Therapeutics focuses on developing immuno-oncology treatments for cancer patients, with a focus o...

August 25, 2023, 3:55 pm

Coya therapeutics to present novel proof of concept exosome modification technology at the 5th exosome based therapeutic development summit in boston, ma on september 7, 2023

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing ...

August 25, 2023, 9:00 am

Quanterix: advancing snfl reference ranges in pediatric neurology

Quanterix specializes in ultra-sensitive digital immunoassay platforms for early disease detection, pot...

August 24, 2023, 11:46 am

Tiziana life sciences investigational therapeutic foralumab in the spotlight at neuroimmunology event

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its investigational therapeutic foralumab will be highlighted by its scientific advisory board chairman D...

August 23, 2023, 8:31 am

Roche reports inadvertent disclosure in lung cancer immunotherapy study

Swiss drug maker Roche said on Wednesday it had been made aware of an inadvertent disclosure in a study of its new ...

August 23, 2023, 2:10 am

immunoprecipitation market to accelerate at a cagr of 5.8%, reaching us$ 1.16 billion by 2033: fact.mr report

Proteomics Research Programs Lighting the Way for immunoprecipitation Providers Rockville , Aug. 22, 20...

August 22, 2023, 11:00 pm

Medigene ag to present at the 8th car-tcr summit in boston

Planegg/ Martins ried , August 22 , 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-...

August 22, 2023, 10:00 am

Apogee therapeutics appoints mark c. mckenna, healthcare veteran and former chairman, president and ceo of prometheus biosciences, as chairman of its board

SAN FRANCISCO and WALTHAM, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company ...

August 21, 2023, 11:30 am


Search within

Pages Search Results: